Aktiespot

Shanghai RAAS Blood Products Co., Ltd. (SHANGHAI RAAS BLOOD PRODUCTS CO) aksje

002252.SZ

¥5.14-0.10 (-1.91%)
Laster graf...

SHANGHAI RAAS BLOOD PRODUCTS CO

Åpning5.19
Høy5.25
Lav5.11
Volum29.12M
P/E25.70
Markedsverdi34.12B
52-ukers høy7.26
52-ukers lav5.11
Gj.sn. volum28.87M
Utbytte0.92%
Beta0.34
EPS0.20

Om Shanghai RAAS Blood Products Co., Ltd. (SHANGHAI RAAS BLOOD PRODUCTS CO) aksje

Shanghai RAAS Blood Products Co., Ltd., together with its subsidiaries, produces and sells blood products in China and internationally. The company offers ALBURAAS, which is albumin prepared from human plasma; GAMARAAS, a human immunoglobulin product for intravenous injections; HEMORAAS, a human coagulation factor VIII product; PROTHORAAS, a human prothrombin complex; FIBRORAAS, a human fibrinogen; FIBINGLURAAS, a fibrin sealant for humans; and THROMBIRAAS, a human thrombin product. It also provides specific immune, human tetanus immunoglobulin, human rabies immunoglobulin, human immunoglobulin, hepatitis B human immunoglobulin, and other blood products. The company exports its products. Shanghai RAAS Blood Products Co., Ltd. was founded in 1988 and is headquartered in Shanghai, China.

Selskapsinformasjon

Børs: Shenzhen (SHZ)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
No. 2009, Wangyuan Road
201401 Shanghai, China
Telefon: + 86 21 2213 0888

Analytikernes aksjeanbefalinger

Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.

Laveste kursmål
Gjennomsnittlig kursmål
Median kursmål
Høyeste kursmål

Andre ser også på: